Establishing accountability by implementing measurable metrics to track and monitor DEI dynamics can ensure that it becomes central to an organization’s strategy.
References
US Food and Drug Administration. FDA Diversity and Inclusion Strategic Plan, 2018–2021 (2017); https://www.fda.gov/media/107939/download
Fry, R. et al. STEM Jobs See Uneven Progress in Increasing Gender, Racial and Ethnic Diversity. Pew Research Center (1 April 2021); https://www.pewresearch.org/science/2021/04/01/stem-jobs-see-uneven-progress-in-increasing-gender-racial-and-ethnic-diversity/
Women in science, technology, engineering, and mathematics (STEM) (quick take). Catalyst (23 August 2022); https://www.catalyst.org/research/women-in-science-technology-engineering-and-mathematics-stem/
Getz, K. et al. Ther. Innov. Regul. Sci. 56, 777–784 (2022).
Anders, G. Who’s vaulting into the C-suite? Trends changed fast in 2022. LinkedIn (1 February 2023); https://www.linkedin.com/pulse/whos-vaulting-c-suite-trends-changed-fast-2022-george-anders/
Shang, Z. et al. Can. Med. Assoc. J. 9, E998–E1004 (2021).
Sue, D. W. et al. Am. Psychol. 62, 271–286 (2007).
Kim, J. Y. & Meister, A. J. Bus. Ethics https://doi.org/10.1007/s10551-022-05203-0 (2022).
Kim, J. Y. & Shang, Z. J. Manage. Stud. https://doi.org/10.1111/joms.12898 (2022).
Kim, J. Y. & Botto, E. The impact of gender microaggressions on team performance in drug development. Applied Clinical Trials (19 May 2022); https://www.appliedclinicaltrialsonline.com/view/the-impact-of-gender-microaggressions-on-team-performance-in-drug-development
Kim, J. Y. & Botto, E. Examining the impact of exclusionary behaviors on team dynamics. Applied Clinical Trials (24 March 2023); https://www.appliedclinicaltrialsonline.com/view/examining-the-impact-of-exclusionary-behaviors-on-team-dynamics
Carr, E. W. et al. The value of belonging at work. Harvard Bus. Rev. (16 December 2019); https://hbr.org/2019/12/the-value-of-belonging-at-work
Chang, E. H. et al. Proc. Natl Acad. Sci. USA 116, 7778–7783 (2019).
Kim, J. Y. & Roberson, L. Consult. Psychol. J. 74, 19–39 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kim, J.Y., Botto, E. What is hindering the drug development industry from achieving diversity, equity and inclusion in its workforce?. Nat Biotechnol 41, 878–879 (2023). https://doi.org/10.1038/s41587-023-01817-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01817-5
- Springer Nature America, Inc.